[go: up one dir, main page]

MX2010010660A - Nuevos complejos de rutenio como catalizadores para reacciones de metatesis. - Google Patents

Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.

Info

Publication number
MX2010010660A
MX2010010660A MX2010010660A MX2010010660A MX2010010660A MX 2010010660 A MX2010010660 A MX 2010010660A MX 2010010660 A MX2010010660 A MX 2010010660A MX 2010010660 A MX2010010660 A MX 2010010660A MX 2010010660 A MX2010010660 A MX 2010010660A
Authority
MX
Mexico
Prior art keywords
catalysts
metathesis reactions
ruthenium complexes
new ruthenium
metathesis
Prior art date
Application number
MX2010010660A
Other languages
English (en)
Inventor
Michelangelo Scalone
Kurt Puentener
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2010010660A publication Critical patent/MX2010010660A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a catalizadores de metátesis novedosos de la fórmula (I), a un proceso para la fabricación de los mismos y a su uso en reacciones de metátesis tales como metátesis con cierre de anillo o metátesis cruzada. La invención se refiere además a un proceso para la manufactura de un compuesto macrocíclico de la fórmula (VII) que tiene el potencial de que va a ser útil como un inhibidor de la proteasa de VHC.
MX2010010660A 2008-04-11 2009-03-30 Nuevos complejos de rutenio como catalizadores para reacciones de metatesis. MX2010010660A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154367 2008-04-11
PCT/EP2009/053711 WO2009124853A1 (en) 2008-04-11 2009-03-30 New ruthenium complexes as catalysts for metathesis reactions

Publications (1)

Publication Number Publication Date
MX2010010660A true MX2010010660A (es) 2010-10-25

Family

ID=40578497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010660A MX2010010660A (es) 2008-04-11 2009-03-30 Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.

Country Status (15)

Country Link
US (1) US7939668B2 (es)
EP (1) EP2276725B1 (es)
JP (1) JP5531008B2 (es)
KR (1) KR101216900B1 (es)
CN (1) CN101970396B (es)
AU (1) AU2009235569B2 (es)
BR (1) BRPI0909205A2 (es)
CA (1) CA2719531C (es)
DK (1) DK2276725T3 (es)
ES (1) ES2388994T3 (es)
IL (1) IL208034A (es)
MX (1) MX2010010660A (es)
PL (1) PL2276725T3 (es)
SI (1) SI2276725T1 (es)
WO (1) WO2009124853A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2282762A2 (en) 2008-04-15 2011-02-16 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis c virus replication
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
CA2760101C (en) 2009-05-07 2013-12-31 F. Hoffmann-La Roche Ag Process for the preparation of ruthenium metathesis complex catalysts
WO2011079439A1 (en) * 2009-12-30 2011-07-07 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for romp and rcm reactions
US8592618B2 (en) * 2010-01-08 2013-11-26 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for ROMP and RCM reactions
WO2011119778A2 (en) 2010-03-24 2011-09-29 Yann Schrodi Method for in-situ formation of metathesis catalysts
US8633280B2 (en) * 2011-03-30 2014-01-21 Zannan Scitech Co., Ltd Methods of modifying polymers with highly active and selective metathesis catalysts
EP2721027B1 (en) * 2011-06-03 2017-05-31 Massachusetts Institute of Technology Z-selective ring-closing metathesis reactions
PL220408B1 (pl) * 2011-09-26 2015-10-30 Inst Chemii Organicznej Polskiej Akademii Nauk Kompleks rutentu, sposób jego wytwarzania oraz zastosowanie
US9850325B2 (en) 2012-03-16 2017-12-26 Zeon Corporation Method for producing ring-opening metathesis polymer hydride, and resin composition
AU2013283680B2 (en) * 2012-06-29 2016-06-16 Apeiron Synthesis S.A. Metal complexes, their application and methods of carrying out of metathesis reaction
CN107233920A (zh) * 2016-03-29 2017-10-10 上海东杰高分子材料有限公司 一种钌络合物催化剂
CN106939026B (zh) * 2017-03-09 2020-03-20 上海克琴科技有限公司 一种钌金属烯烃复分解催化剂的制备及其应用
CN109280074A (zh) * 2017-07-20 2019-01-29 歌礼药业（浙江）有限公司 丹诺瑞韦钠晶体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2811507A (en) * 1954-10-20 1957-10-29 Koppers Co Inc Alkenylaryloxyacetamides
US5936100A (en) * 1996-12-16 1999-08-10 Studiengesellschaft Kohle Mbh Synthesis of functionalized macrocycles by ring closing metathesis
EP0921129A1 (en) * 1997-12-03 1999-06-09 Studiengesellschaft Kohle mbH Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions
CN1771257A (zh) * 2003-04-10 2006-05-10 贝林格尔·英格海姆国际有限公司 通过钌络合物催化的易位反应制备大环化合物的方法
ATE422895T1 (de) 2003-04-16 2009-03-15 Bristol Myers Squibb Co Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
DE10335416A1 (de) * 2003-08-02 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Metathesekatalysatoren
RS20110578A3 (en) 2003-10-14 2016-02-29 F. Hoffmann-La Roche Ltd MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
US7491794B2 (en) 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
BRPI0509467A (pt) * 2004-03-30 2007-09-11 Intermune Inc compostos macrocìclicos como inibidores de replicação viral
WO2006033851A1 (en) * 2004-09-17 2006-03-30 Boehringer Ingelheim International, Gmbh Ring-closing metathesis process in supercritical fluid
KR101294467B1 (ko) 2005-07-25 2013-09-09 인터뮨, 인크. Ｃ형 간염 바이러스 복제의 신규 거대고리형 억제제
DE102006044699A1 (de) 2006-09-22 2008-04-03 Bayerische Motoren Werke Ag Tragrohr einer Instrumententafel eines Kraftfahrzeugs

Also Published As

Publication number Publication date
US7939668B2 (en) 2011-05-10
PL2276725T3 (pl) 2012-11-30
BRPI0909205A2 (pt) 2015-08-11
JP5531008B2 (ja) 2014-06-25
AU2009235569A1 (en) 2009-10-15
SI2276725T1 (sl) 2012-09-28
CN101970396B (zh) 2014-06-18
WO2009124853A1 (en) 2009-10-15
US20090275714A1 (en) 2009-11-05
AU2009235569B2 (en) 2012-03-29
JP2011522778A (ja) 2011-08-04
CA2719531C (en) 2013-03-19
IL208034A (en) 2014-09-30
CN101970396A (zh) 2011-02-09
IL208034A0 (en) 2010-12-30
EP2276725B1 (en) 2012-07-04
ES2388994T3 (es) 2012-10-22
CA2719531A1 (en) 2009-10-15
EP2276725A1 (en) 2011-01-26
KR101216900B1 (ko) 2012-12-28
KR20100127822A (ko) 2010-12-06
DK2276725T3 (da) 2012-08-20

Similar Documents

Publication Publication Date Title
MX2010010660A (es) Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.
GEP20125652B (en) cMET INHIBITORS
TW200616646A (en) Synthesis of boronic ester and acid compounds
ATE543854T1 (de) Neue polycarbonat-polyorganosiloxan- und/oder polyurethan-polyorganosiloxan-verbindungen
PT2470546E (pt) Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor
MX2011005934A (es) Compuestos organicos.
MY150596A (en) Hsp90 inhibitors
MX340572B (es) Proceso para la fabricacion de compuestos farmaceuticamente activos.
TNSN07383A1 (en) 1-h-quinazoline-2,4-diones and their use as ampa-receptor ligands
PT2382198E (pt) Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
MX2012002385A (es) Inhibidores macrociclicos de cinasa janus.
JO2818B1 (en) A new process for the installation of agililatine
ATE485052T1 (de) Kovalenter faktor vii-gewebefaktor-komplex
IL195868A0 (en) New ruthenium complexes as catalysts for metathesis reactions
NZ586187A (en) Processes for the synthesis of sinomenine derivatives and their intermediate
BRPI0813870A2 (pt) Síntese catalisada por metal de transição de 2h-indazóis.
MX2009004343A (es) Compuestos organicos.
SG151207A1 (en) New process for the synthesis of strontium ranelate and its hydrates
GB0508318D0 (en) Organic compounds
MX2009004983A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
TW200640914A (en) Novel processes for the preparation of a benzofuran
UA106195C2 (ru) Способ синтеза агомелатина
TW200728310A (en) Process for the preparation of ferri-succinylcasein

Legal Events

Date Code Title Description
FG Grant or registration